Group Leader opportunity in data science
An opportunity has arisen for a talented data scientist to join the Kennedy Institute Faculty to spearhead the application of data science-based approaches for discovery in immune-mediated inflammatory disease.
Many areas of biological and clinical science are undergoing a data revolution and research into inflammatory disease is no exception. Increasingly, researchers at the Kennedy Institute are applying genomic and proteomic technologies, including multi-modal single cell approaches and metagenomics, to generate rich datasets describing the cells, genes and microbes that associate with tissue health or immune-mediated inflammatory disease.
Studies span disease models, as well as large patient cohorts, for discovery and understanding of the molecular pathways that drive disease onset or predict outcomes. To support this approach, a strong core of technologies and expertise in single-cell genomics, statistical genetics, microbial genomics, and computational biology has been established, together with a facility for the curation and warehousing of meta-data to integrate experimental and clinical datasets.
The Institute building is now being fitted out with a new floor to support computationally-intensive research for scale up in data science. The new space creates an opportunity for a talented Group Leader to join the Institute's faculty to lead in the adoption of data-science based approaches for understanding immune-mediated inflammatory disease.
The Group Leader will be awarded a Senior Research Fellowship by the Kennedy Trust for Rheumatology Research to support the launch of an independent research laboratory. They will lead an internationally competitive research programme harnessing existing opportunities within Oxford and at other partner sites, such as the Arthritis Therapy Acceleration Programme, the NIHR Oxford Biomedical Research Centre, the Human Cell Atlas and the Oxford Medical Sciences COVID-19 immunology initiative, for analysis of complex datasets across different types of immune-mediated inflammatory disease.
The role also creates an exciting opportunity to forge new partnerships within Oxford and externally to facilitate interdisciplinary research programmes that complement and build on existing strengths at the Institute.